> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Pediatric Safety Studies
- URL: https://www.fdaweb.com/workshop-on-pediatric-safety-studies/
- Published: 2016-03-14T12:00:00.000Z
- Updated: 2026-09-15T02:43:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135072

*Federal Register* Notice: FDA’s Office of Pediatric Therapeutics and CDER are announcing a two-day public workshop 4/13-14 entitled “Advancing the Development of Pediatric Therapeutics: Successes and Challenges of Performing Long-Term Pediatric Safety Studies.” Its purpose is for FDA to have an open discussion with experts in the field examining the need and path forward for long-term pediatric safety studies. Day 1 of the public workshop will focus on an exposition of the successes and challenges of long-term safety studies in children. Day 2 will focus on suggestions for the future on study design and implementation of long-term safety studies in children. Viewpoints of patient representatives of children with chronic conditions and industry will be included. The workshop will be held from 8 a.m. to 5 p.m. at The DoubleTree by Hilton Hotel--Bethesda, 8120 Wisconsin Ave., Bethesda, MD. Contact **Renan A. Bonnel**, (301) 796-8654\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-03-14/pdf/2016-05621.pdf?ref=fdaweb.com)